Spiriva



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Chronic Obstructive Pulmonary Disease 49.5%
Hypertension 9.2%
Emphysema 7.3%
Asthma 6.7%
Blood Cholesterol Increased 4.0%
Dyspnoea 4.0%
Prophylaxis 2.3%
Gastrooesophageal Reflux Disease 1.9%
Diabetes Mellitus 1.9%
Cardiac Disorder 1.8%
Bronchitis Chronic 1.7%
Anxiety 1.5%
Depression 1.4%
Hypothyroidism 1.4%
Supplementation Therapy 1.2%
Atrial Fibrillation 1.0%
Pain 0.8%
Arthritis 0.8%
Hypersensitivity 0.7%
Bronchitis 0.7%
Incorrect Route Of Drug Administration 55.0%
Dyspnoea 12.3%
Drug Ineffective 9.6%
Product Quality Issue 3.3%
Pneumonia 2.4%
Vision Blurred 2.3%
Death 1.8%
Off Label Use 1.7%
Dry Mouth 1.6%
Urinary Retention 1.5%
Wheezing 1.5%
Chronic Obstructive Pulmonary Disease 1.0%
Cough 0.9%
Dysphonia 0.8%
Rash 0.8%
Throat Irritation 0.8%
Lung Neoplasm Malignant 0.8%
Malaise 0.7%
Urinary Tract Infection 0.7%
Headache 0.7%
Secondary
Chronic Obstructive Pulmonary Disease 40.5%
Emphysema 11.6%
Asthma 9.7%
Dyspnoea 7.9%
Hypertension 6.3%
Bronchitis Chronic 3.7%
Product Used For Unknown Indication 3.0%
Blood Cholesterol Increased 2.4%
Drug Use For Unknown Indication 1.7%
Bronchitis 1.6%
Prophylaxis 1.6%
Depression 1.3%
Cardiac Disorder 1.3%
Diabetes Mellitus 1.3%
Gastrooesophageal Reflux Disease 1.2%
Atrial Fibrillation 1.1%
Anxiety 1.1%
Hypothyroidism 0.9%
Lung Disorder 0.9%
Osteoporosis 0.7%
Incorrect Route Of Drug Administration 68.8%
Dyspnoea 7.7%
Drug Ineffective 6.7%
Pneumonia 2.6%
Vision Blurred 1.8%
Wheezing 1.3%
Urinary Retention 1.2%
Off Label Use 1.1%
Dry Mouth 1.1%
Product Quality Issue 0.9%
Cough 0.9%
Hypersensitivity 0.7%
Weight Increased 0.7%
Dysgeusia 0.7%
Urticaria 0.7%
Vomiting 0.6%
Urinary Tract Infection 0.6%
Chronic Obstructive Pulmonary Disease 0.6%
Dysphonia 0.6%
Visual Acuity Reduced 0.6%
Concomitant
Product Used For Unknown Indication 25.0%
Drug Use For Unknown Indication 15.4%
Chronic Obstructive Pulmonary Disease 15.3%
Asthma 8.6%
Hypertension 5.7%
Pain 3.3%
Osteoporosis 2.7%
Non-small Cell Lung Cancer 2.6%
Emphysema 2.4%
Rheumatoid Arthritis 2.3%
Depression 2.2%
Smoking Cessation Therapy 2.1%
Prophylaxis 2.1%
Atrial Fibrillation 1.9%
Diabetes Mellitus 1.7%
Gastrooesophageal Reflux Disease 1.6%
Pulmonary Arterial Hypertension 1.6%
Anxiety 1.3%
Hypersensitivity 1.1%
Dyspnoea 1.1%
Pneumonia 11.8%
Dyspnoea 9.0%
Vomiting 9.0%
Weight Decreased 8.2%
Death 6.9%
Weight Increased 6.6%
Chronic Obstructive Pulmonary Disease 5.0%
Nausea 4.6%
Wheezing 4.5%
Respiratory Failure 4.0%
Product Quality Issue 3.8%
Drug Ineffective 3.7%
Pyrexia 3.3%
Tremor 3.2%
Renal Failure Acute 2.9%
Urinary Tract Infection 2.9%
Rash 2.9%
Oedema Peripheral 2.7%
Pain In Extremity 2.4%
Somnolence 2.4%
Interacting
Chronic Obstructive Pulmonary Disease 28.8%
Emphysema 21.2%
Asthma 18.5%
Smoking Cessation Therapy 11.6%
Hypertension 2.7%
Constipation 2.1%
Drug Use For Unknown Indication 2.1%
Depression 1.4%
Ex-smoker 1.4%
Ex-tobacco User 1.4%
Gastrooesophageal Reflux Disease 1.4%
Respiratory Tract Infection 1.4%
Venous Stasis 1.4%
Anxiety 0.7%
Arthritis 0.7%
Back Pain 0.7%
Blood Pressure Diastolic Abnormal 0.7%
Bronchitis Chronic 0.7%
Cardiac Disorder 0.7%
Cystitis 0.7%
Weight Increased 15.0%
Vomiting 12.5%
Drug Interaction 10.0%
Dyspnoea 10.0%
Tachycardia 7.5%
Pneumonia 5.0%
Respiratory Tract Infection 5.0%
Tongue Disorder 5.0%
Tremor 5.0%
Drug Ineffective 2.5%
Dysphonia 2.5%
Headache 2.5%
Hypogammaglobulinaemia 2.5%
Lung Disorder 2.5%
Muscular Weakness 2.5%
Purpura 2.5%
Respiratory Distress 2.5%
Shoulder Operation 2.5%
Wheezing 2.5%